CAC-40 Plunges As Vaccine Efficacy, Economic Data Ruin Sentiment

The CAC-40 plunged into losses in Tuesday's trade as world markets responded to a vaccine maker's concerns about vaccine efficacy. Moderna's CEO expressed apprehensions about the effectiveness of vaccines against the newly identified Omicron variant. Accelerating inflation in the Euro Area and the unexpected decline in homeland's domestic consumption exacerbated the negative sentiment.